Title Tumori bubrega Title (english) Kidney tumors Author Mladen Sorić Mentor Boris Ružić (mentor)Committee member Željko Kaštelan (predsjednik povjerenstva)Committee member Tomislav Meštrović (član povjerenstva)Committee member Boris Ružić (član povjerenstva)Granter University of Zagreb Defense date and country 2019-07-12, Croatia Scientific / art field, BIOMEDICINE AND HEALTHCARE Scientific / art field, BIOMEDICINE AND HEALTHCARE Abstract Pod pojmom tumori bubrega spada širok raspon međusobno jako različitih tvorbi. Uobičajena je podjela na benigne i maligne. U benigne tumore bubrega spadaju: onkocitom, angiomiolipom, lejomiom, metanefritični adenom, papilarni adenom, cistični nefrom i reninom. Onkocitom je tumor epitelnog porijekla sastavljen od onkocita i najčešći je od benignih tumora bubrega. Angiomiolipom je tumor mezenhimalnog porijekla sastavljen od tri vrste tkiva, izaziva bubrežno krvarenje češće nego bilo koji tumor bubrega, a, također, njegov klasični tip je jedina vrsta benignog tumora bubrega koja se moţe pouzdano dijagnosticirati radiološki. Lejomiom je tumor porijeklom od glatkih mišićnih stanica. Metanefritični adenom je rijetki tumor epitelnog porijekla te češće uzrokuje policitemiju nego ostale vrste tumora bubrega. Papilarni adenom je epitelna lezija tubulopapilarne arhitekture. Cistični nefrom je rijetka cistična bubrežna lezija, spada u skupinu miješanih mezenhimalnih i epitelnih tumora. U maligne tumore bubrega spadaju: karcinomi bubrega, Wilmsov tumor i sekundarni tumori bubrega. Karcinomi bubrega su adenokarcinomi porijeklom od epitelnih stanica bubrežnog tubula, najsmrtonosniji su tumori urogenitalnog sustava. Wilmsov tumor je bubrežna neoplazma embrionalnog porijekla te je najučestaliji maligni tumor bubrega kod djece. Uz benigne i maligne tumore koji spadaju u primarne bubrežne tumore, sekundarni tumori bubrega čine najbrojnije maligne neoplazme ovog organa (četiri puta su češći od primarnih), a prvo mjesto po učestalosti zauzimaju metastaze karcinoma pluća, zatim dojke te gastrointestinalnog sustava.
Abstract (english) The term kidney tumors includes a wide range of mutually distinct entities. The common division is on benign and malignant tumors. Benign kidney tumors include oncocytoma, angiomyolipoma, leiomyoma, metanephrithic adenoma, papillary adenoma, cystic nephroma and reninoma. Oncocytoma is a tumor of epithelial origin composed of oncocytes and is the most common of benign kidney tumors. Angiomyolipoma is a tumor of mesenchymal origin composed of three types of tissue, causing kidney bleeding more frequently than any other kidney tumor, and also its classical type is the only type of benign renal tumor that can be reliably diagnosed radiologically. Leiomyoma is a tumor originating from smooth muscle cells. Metanephritic adenoma is a rare tumor of epithelial origin and more often causes polycythemia than any other type of kidney tumors. Papillary adenoma is an epithelial lesion of tubulopapillary architecture. Cystic nephroma is a rare cystic kidney disease, belongs to a group of mixed mesenchymal and epithelial tumors. Malignant kidney tumors include: kidney carcinomas, Wilms tumor and secondary kidney tumors. Kidney carcinomas are adenocarcinoma derived from epithelial cells of the renal tubule and are the most deadly of all urogenital cancers. Wilms tumor is a renal neoplasm of embryonic origin and is the most common malignant kidney tumor in children. With the benign and malignant tumors that fall into primary renal tumors, secondary tumors are the most malignant neoplasms of this organ (four times more common than the primary ones), and at the first place is metastasis of lung cancer, then breast cancer and gastrointestinal tract carcinoma metastasis.
Keywords
tumori bubrega
benigni tumori bubrega
karcinomi bubrega
Keywords (english)
kidney tumors
benign kidney tumors
kidney carcinomas
Language croatian URN:NBN urn:nbn:hr:105:876222 Study programme Title: Medicine Type of resource Text File origin Born digital Access conditions Open access Terms of use Created on 2020-01-27 15:02:21
